|
|
Article: An Essential Competitor Analysis Report on Human Growth Hormones (hGH): Biosimilar Pricing Is Not Enough, Convenience Will Mandate.
- Article from:
- M2 Presswire
- Article date:
- November 26, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-26 November 2008-Research and Markets: An Essential Competitor Analysis Report on Human Growth Hormones (hGH): Biosimilar Pricing Is Not Enough, Convenience Will Mandate(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:26112008
Dublin - Research and Markets (http://www.researchandmarkets.com/research/R6c5438/competitor_analysi) has announced the addition of the "Competitor Analysis: Human Growth Hormone (hGH)" report to their offering.
The Competitive Intelligence Report Human Growth Hormone (hGH) as of October 2008 provides a competitor analysis in the development pipeline of biosimilar (biogeneric) versions of somatropin and next ...